|
⚲
|
| Keyboard |
| Calamari Christopher J
✚
|
|
|---|---|
| CIK # | 0001868518 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001868518] | |
| 4 | [0001868518] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Abbott Laboratories | |
| Calamari Christopher J |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Abbott Laboratories ABT
Common shares without par value
|
2023-02-28 | Tax withheld | 2,827 | $99.77 | 282,050 |
|
Abbott Laboratories ABT
Option (right to buy) · derivative
|
2023-02-17 | Grant | 41,648 | $0.00 | |
|
Abbott Laboratories ABT
Common shares without par value
|
2023-02-17 | Grant | 10,560 | $0.00 | |
|
Abbott Laboratories ABT
Common shares without par value
|
2022-07-01 | Tax withheld | 569 | $108.65 | 61,822 |
|
Abbott Laboratories ABT
Common shares without par value
|
2022-03-01 | Sell | 706 | $118.15 | 83,414 |
|
Abbott Laboratories ABT
Common shares without par value
|
2022-02-28 | Tax withheld | 2,368 | $122.41 | 289,867 |
|
Abbott Laboratories ABT
Option (right to buy) · derivative
|
2022-02-18 | Grant | 59,708 | $0.00 | |
|
Abbott Laboratories ABT
Common shares without par value
|
2022-02-18 | Grant | 12,812 | $0.00 | |
|
Abbott Laboratories ABT
Common shares without par value
|
2021-07-01 | Grant | 3,764 | $0.00 | |
|
Abbott Laboratories ABT
Option (right to buy) · derivative
|
2021-07-01 | Grant | 19,291 | $0.00 |